The loss of Fate Therapeutics under GAAP for 6 months of 2020 was $61,592 million, up 42.3% from $43,238 million in the previous year. Revenues increased by 46.4% to $7.98 million compared to $5.449 million a year earlier.
The loss of Fate Therapeutics under GAAP for 6 months of 2020 was $61,592 million, up 42.3% from $43,238 million in the previous year. Revenues increased by 46.4% to $7.98 million compared to $5.449 million a year earlier. 
ir.fatetherapeutics.com
English (US) 